| Accession Number: | 0000914190-19-000329 |
| Date: | 2019-08-19 |
| Issuer: | BIO-TECHNE CORP (TECH) |
| Original Submission Date: |
KUMMETH CHARLES R.
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2019-08-19 | M | 24,979 | a | $0.00 | 135,856 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2019-08-19 | deemed execution date | M | 24,979 (d) | common stock 24,979 | $0.00 | 0 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 67.46 | 2019-08-19 | deemed execution date | 0 ( ) | 2020-04-01 | common stock 57,590 | $67.46 | 57,590 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 86.25 | 2019-08-19 | deemed execution date | 0 ( ) | 2021-04-01 | common stock 46,316 | $86.25 | 46,316 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 94.35 | 2019-08-19 | deemed execution date | 0 ( ) | 2021-08-12 | common stock 66,849 | $94.35 | 66,849 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 108.49 | 2019-08-19 | deemed execution date | 0 ( ) | 2022-08-07 | common stock 79,517 | $108.49 | 79,517 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 106.59 | 2019-08-19 | deemed execution date | 0 ( ) | 2023-08-18 | common stock 154,169 | $106.59 | 154,169 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 106.59 | 2019-08-19 | deemed execution date | 0 ( ) | 2023-08-18 | common stock 102,779 | $106.59 | 102,779 | direct | |||
| RESTRICTED STOCK UNITS | 0.0 | 2019-08-19 | deemed execution date | 0 ( ) | common stock 21,291 | $0.00 | 21,291 | direct | ||||
| STOCK OPTIONS (RIGHT TO BUY) | 125.05 | 2019-08-19 | deemed execution date | 0 ( ) | 2024-08-09 | common stock 117,342 | $125.05 | 117,342 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 125.05 | 2019-08-19 | deemed execution date | 0 ( ) | 2024-08-09 | common stock 78,228 | $125.05 | 78,228 | direct | |||
| RESTRICTED STOCK UNITS | 0.0 | 2019-08-19 | deemed execution date | 0 ( ) | common stock 16,918 | $0.00 | 16,918 | direct | ||||
| STOCK OPTIONS (RIGHT TO BUY) | 177.32 | 2019-08-19 | deemed execution date | 0 ( ) | 2025-08-08 | common stock 90,334 | $177.32 | 90,334 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 177.32 | 2019-08-19 | deemed execution date | 0 ( ) | 2025-08-08 | common stock 60,222 | $177.32 | 60,222 | direct | |||
| RESTRICTED STOCK UNITS | 0.0 | 2019-08-19 | deemed execution date | 0 ( ) | common stock 16,937 | $0.00 | 16,937 | direct | ||||
| STOCK OPTIONS (RIGHT TO BUY) | 190.41 | 2019-08-19 | deemed execution date | 0 ( ) | 2026-08-07 | common stock 85,725 | $190.41 | 85,725 | direct | |||
| STOCK OPTIONS (RIGHT TO BUY) | 190.41 | 2019-08-19 | deemed execution date | 0 ( ) | 2026-08-07 | common stock 57,150 | $190.41 | 57,150 | direct |
| ID | footnote |
|---|---|
| f1 | each restricted stock unit represents a contingent right to receive one share of bio-techne common stock. |
| f2 | includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on august 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on august 8, 2020 and as to 3,759 shares on august 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of august 7, 2020 and august 7, 2021 and as to 3,763 shares on august 7, 2022. |
| f3 | fully exercisable. |
| f4 | on 8/19/2019, the board of directors certified vesting of 24,979 performance rsus. |
| f5 | options to purchase 25,695 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 25,695 shares vest on 8/18/2020. |
| f6 | vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |
| f7 | options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021. |
| f8 | vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |
| f9 | options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022. |
| f10 | vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |
| f11 | options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023. |
